Profil
Gregory E.
Papaz is currently the President of Newfield Therapeutics Corp.
He was previously the President & CEO of PAION, Inc. and Senior Vice President-US Commercial Operations at Optimer Pharmaceuticals LLC.
Papaz holds an MBA from Cornell University and an undergraduate degree from Providence College.
Postes actifs de Gregory E. Papaz
| Sociétés | Poste | Début |
|---|---|---|
Newfield Therapeutics Corp.
Newfield Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel diagnostic and therapeutic oncological products | President | 01/02/2018 |
Anciens postes connus de Gregory E. Papaz
| Sociétés | Poste | Fin |
|---|---|---|
PAION, Inc.
PAION, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Directeur Général | 01/03/2017 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products | Corporate Officer/Principal | 11/12/2012 |
Formation de Gregory E. Papaz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Providence College
Providence College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products | Health Technology |
PAION, Inc.
PAION, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Newfield Therapeutics Corp.
Newfield Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel diagnostic and therapeutic oncological products | Health Technology |
















